There has been some exciting news recently with EpiVax announcing that it has made great strides in developing precision cancer immunotherapies. You can check out one the 'Freshest' articles on them here: https://www.prnewswire.com/news-releases/epivax-oncology-completes-a-1-2m-bridge-financing-300665275.html Amaz
This blog is still a work in progress. Although I've made great strides in my research into computational genomics I have really struggled to make any headway on sharing these learnings. Thank you so much for your support, I am sure we will get better at the site editing soon. Stay well, Amaz.
Obviously due to the rapidly changing environment surrounding the pandemic this has setback much of our learning & reading. I will do my best to update you again soon.
Comments
Post a Comment